Literature DB >> 12562014

Evaluation of rabies virus neutralizing antibody titres induced by intramuscular inoculation of rabies DNA vaccine in mice and Bonnet monkeys (Macaca radiata).

S Biswas1, A P Kalanidhi, M S Ashok, G S Reddy, V A Srinivasan, P N Rangarajan.   

Abstract

A rabies DNA vaccine consisting of plasmid DNA expressing the rabies virus surface glycoprotein was injected (im) twice at two week interval to outbred swiss mice or Bonnet monkeys (Macaca radiata) and the levels of rabies virus neutralizing antibody (VNA) titres were examined over a one year period. In mice, the VNA titre was maintained above the minimum protective level (0.5 I.U./ml) up to 10 months after primary immunization, while in monkeys, the titre dropped below the protective level by 6 months. An anamnestic B cell response was seen in both mice and monkeys following the administration of a booster dose, 10 and 6 months after the primary immunization, respectively. These results indicate that im injection of rabies DNA vaccine induces VNA in nonhuman primates and mice unlike intradermal (id) immunization, which was shown to induce VNA only in mice but not in monkeys. This is the first report on the induction of VNA in nonhuman primates by im inoculation of rabies DNA vaccine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12562014

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  4 in total

1.  Pre-clinical toxicity & immunobiological evaluation of DNA rabies vaccine & combination rabies vaccine in rhesus monkeys (Macaca mulatta).

Authors:  B Dinesh Kumar; P Uday Kumar; T Prasanna Krishna; S Kalyanasundaram; P Suresh; V Jagadeesan; S Hariharan; A Nadamuni Naidu; Kamala Krishnaswamy; P N Rangarajan; V A Srinivasan; G S Reddy; B Sesikeran
Journal:  Indian J Med Res       Date:  2013-06       Impact factor: 2.375

2.  DNA vaccines: Getting closer to becoming a reality.

Authors:  Kaushik Bharati; Sudhanshu Vrati
Journal:  Indian J Med Res       Date:  2013-06       Impact factor: 2.375

Review 3.  Lyssaviruses: current trends.

Authors:  Susan A Nadin-Davis; Christine Fehlner-Gardiner
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

Review 4.  The strategic use of novel smallpox vaccines in the post-eradication world.

Authors:  Joseph W Golden; Jay W Hooper
Journal:  Expert Rev Vaccines       Date:  2011-07       Impact factor: 5.683

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.